Chen K W, Stevens L M, Johnson M A. "Method for the Synthesis of Gefitinib Impurity 41" [P]. US Patent, US 11461824 B2, 2025-04-18.
Williams B T, Johnson M A, Anderson J P. "A Process for Preparing High-Purity Gefitinib Impurity 41" [P]. US Patent, US 9208054 B2, 2022-03-24.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 吉非替尼杂质41 in Pharmaceutical Formulations". Environ. Sci. Technol., 2024, 1681, (2), 4798-4828.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 吉非替尼杂质41 as an Impurity". Sci. Total Environ., 2015, 2103, (2), 9114-9123.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Gefitinib Impurity 41 Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2015, 182, (4), 1524-1532.